Estrategias Combinadas en Inmunoterapia Traslacional
ITC
Centre Hospitalier de l’Université de Montréal
Montreal, CanadáCentre Hospitalier de l’Université de Montréal-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2022
-
Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial
Journal for immunotherapy of cancer, Vol. 10, Núm. 8
2011
-
Defining the critical hurdles in cancer immunotherapy
Journal of Translational Medicine